6th ICHNO SCIENTIFIC PROGRAMME

 

Programme Book and Exhibition Guide

Abstract Book 

 

6th ICHNO SCIENTIFIC PROGRAMME OVERVIEW

THURSDAY 16 MARCH 2017

 

 

TIME SLOTS

SESSION DETAILS

09:00-09:15

Opening remarks

H. Langendijk (ESTRO) / CR Leemans (EHNS) / J-P Machiels (ESMO)

09:15-09:45

Keynote lecture 1: Immunotherapy for head and neck cancer: integrating the fourth modality

Chair: H. Langendijk (NL) / CR Leemans (NL) / J-P Machiels (BE)

Speaker: R. Ferris (US)

09:45-10:15

Keynote lecture 2: State of the art in robotic surgery

Chair: H. Langendijk (NL) / CR Leemans (NL) / J-P Machiels (BE)

Speaker: E. Moore (US)

10:15-10:45

Coffee break

10:45-12:00

Symposium 1: Prognostic modelling

Chair: R. Brakenhoff (NL)  
Chair: JP Klussmann (DE)

Radiomics: the poor man molecular imaging?  - P. Lambin (NL)  
Novel insights into head and neck cancer by transcriptome approaches - L. De Cecco (IT)  
The TRIPOD Guideline - J. B. Reitsma (NL)

12:00-13:00

Proffered papers 1

Chair: M. Merlano (IT)

Outcomes of Head and Neck Cancer with N3 Nodal Disease:  A Review of the National Cancer Data Base - H.C. Ko (US)

Sentinel node biopsy for early stage oral cancer; experience of 2 Dutch Head and Neck centers - I. den Toom (NL)

Incidence of malignant disease outside the head and neck region in head and neck cancer - M. Bernsdorf (DK)

Validation of a prognostic model in 600 patients with squamous cell carcinoma - J. Rasmussen (DK)

Discussant: P. Nicolai (IT)

13:00-14:30

Lunch and Satellite symposium

14:30-16:00

New data from randomised trials

Chair: J. Vermorken (BE)

Update of the meta-analysis of chemotherapy in head and neck cancer (MACH-NC)  - P. Blanchard (FR) 

Discussant - L. Licitra (IT) 

Update of PET NECK trial - H. Mehanna (UK) 

Discussant - W. Budach (DE) 

Update of neck dissection trial - AK D’Cruz (IN)

Discussant - R. de Bree (NL) 

Update on the ARCON study - H. Kaanders (NL)

Discussant S. Nuyts (BE) 

16:00-16:30

Coffee break

16:30-17:45

Symposium 2Reductions of radiation induced toxicities

Chair: W. Budach (DE)  
Chair: J. Giralt (ES)

Target volume reduction – W. de Neve (BE)  
Prophylactic swallowing exercises in head and neck radiotherapy - H. Mortensen (DK)  
The value of proton therapy for head and neck malignancies: reducing side effects and improving outcomes  - P. Blanchard (FR)

17:55-18:55

Satellite symposium

19:00-20:00

Welcome reception

 

 

FRIDAY 17 MARCH

 

TIME SLOTS

SESSION DETAILS

09:00-09:30

Keynote lecture 3: New imaging techniques

Chair: L. Licitra (IT) 
Chair: M. Quer (ES)

Speaker: R. Maroldi (IT)

09:30-10:00

Keynote lecture 4: HNC Biomarkers - how do we translate biology into useful assays for clinical care?

Chair: L. Licitra (IT) 
Chair: M. Quer (ES)

Speaker: T. Seiwert (US)

10:00-10:30

Coffee break

10:30-11:30

Proffered papers 2

Chair: P. Szturz (CZ) 

The phase III study INTERCEPTOR: preliminary results - N. Denaro (IT)

Sarcopenia predicts chemotherapy dose-limiting toxicity in patients with head and neck cancer - S. Bril (NL)

Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN - D. Soulières (CA)

Association of patient derived xenograft formation with oral cavity squamous cell cancer outcomes - A. Hope (CA)

Discussant: J. Vermorken (BE)

11:30-12:45

Symposium 3: New developments in surgery

Chair: P. Nicolai (IT) 
Chair: K. Harrington (UK)

New developments in sentinel node biopsy of head and neck cancer  – S. Stoeckli (CH) 
Integrated 3D virtual visualization of pathology and reconstructive planning in head & neck cancer – M. Witjes (NL) 
Oropharyngeal surgery – T. Jones (UK)

12:45-14:15

Lunch and Satellite symposium

14:15-15:15

Interactive tumour board session: Limited T4a larynx cancer

Chair: HE Eckel (AT)

Panellists: A. Argiris (GR), A. Castro (PT), D. Chevalier (FR), JG. Eriksen (DK), W. Golusinski (PL), S. Tribius (DE) 

15:15-16:00

Poster discussion

Chair: C. Simon (CH) 

Correlation and prognostic impact of HPV and p16 on RT-outcome in larynx and hypopharynx cancer - P. Lassen (DK)

cfHPV DNA as a marker of treatment results in patients with HPV-related head and neck cancer - T. Rutkowski (PL)

Prognostic and predictive impact of HPV status in oropharyngeal cancer: the MARCH-HPV project - B. Lacas (FR)

Discussant: J. Hess (DE)

Causes-of-death underestimate the burden of head and neck cancers in France (EPICORL study) - Y. Pointreau (FR)

Survival of patients with head and neck cancers in France (EPICORL study) - F. Huguet (FR)

Quality of life, health status and work in head and neck cancer survivors treated with radiotherapy - A. Matias Perez (ES)

Discussant: A. Mäkitie (FI)

Pharyngeal constrictor muscle dose correlated with dysphagia after radiotherapy in head and neck - J. Miroir (FR)

Cetuximab + RT shows an excellent long term OS in patients with both high ADCC and high EGFR - M. Merlano (IT)

Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer - E. Orlandi (IT)

Discussant: D. Raben (US)

16:00-16:30

Coffee break

16:30-17:45

Symposium 4: New developments in systemic treatment

Chair: JE Bakema (NL) 
Chair: J. Vermorken (BE)

Is there still a role for targeted signaling agents in H&N cancer? – C. Le Tourneau (FR) 
Immunity and immune toxicity: Clinical management of immune checkpoint inhibition – U. Keilholz (DE) 
Immunotherapy beyond anti PD1 inhibitors – P. Coulie (BE)

SATURDAY 18 MARCH

 

TIME SLOTS

SESSION DETAILS

08:45-09:15

Keynote lecture 5: Clinical implementation of adaptive radiotherapy: challenges ahead

Chair: V. Budach (DE)  
Chair: A. Mäkitie (FI)

Speaker: O. Hamming (NL)

09:15-10:30

Symposium 5: Adenoid cystic carcinoma

Chair:  R. de Bree (NL)  
Chair: S. Faivre (FR)

Adenoid cystic carcinoma: considerations in surgical approach and factors modifying expected outcome following treatment – V. Vander Poorten (BE)  
Radiotherapy in the adenoid cystic carcinoma of the H&N – A. Jensen (DE)  
When to treat and how to treat distant metastases – P. Bossi (IT)

10:30-11:00

Coffee break

11:00-12:00

Proffered papers 3

Chair: V. Vander Poorten (BE)

Re-irradiation with curative intent of squamous cell carcinomas of the head and neck in Denmark - B.E. Engelmann (DK)

Re-irradiation in Head and Neck Cancers: A single institution Prospective Cohort Study - R. Salunkhe (IN)

ART DECO (CRUK/10/018): dose escalated vs standard dose IMRT in locally advanced head & neck cancer - M. Beasley (UK)

Recurrence patterns after 40 Gy to the elective treated neck in head and neck cancer - D. Nevens (BE)

Discussant: C. Grau (DK)

12:00-13:00

Debate 1Early stage HPV related oropharyngeal cancer should not be treated with radiotherapy anymore

Chair: V. Gregoire (BE)  
Chair: R. Simo (UK)

For the motion: C. Simon (CH)  
Against the motion: V. Budach (DE)

For the motion: J. Klozar (CZ)  
Against the motion: J. Giralt (ES)

13:00-13:15

Concluding remarks

H. Langendijk (ESTRO) / CR Leemans (EHNS) / J-P Machiels (ESMO)

downloads